Xing X, Shi J, Jia Y, Dou Y, Li Z, Dong B, Guo T, Cheng X, Li X, Du H, Hu Y, Jia S, Zhang J, Li Z, Ji J. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis,Journal for Immunotherapy of Cancer,2022 Mar;10(3):e003984.

Xiao-Huan Tang# , Ting Guo#, Xiang-Yu Gao #， Xiao-Long Wu, Xiao-Fang Xing*, Jia-Fu Ji*, Zi-Yu Li*. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications,Molecular Cancer,2021 Jul 30;20(1):99.

Guo Ting#, Bai Yanhua#, Cheng XiaoJing, Han Haibo, Du Hong, Hu Ying, Jia Shuqin*, Xing Xiaofang*, Ji Jiafu*. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.,Cancer Commun (Lond),2021; 41: 258-272.

Yang Du#, Meng Cai#, Xiaofang Xing#, Jiafu Ji, Ence Yang*, Jianmin Wu*. PINA 3.0: mining cancer interactome.,Nucleic Acids Research,2021; 49: D1351-D1357

Li Ziyu#, Jia Yongning#, Zhu Honglin#, Xing Xiaofang#, Pang Fei, Shan Fei, Li Shuangxi, Wang Danhua, Zhao Fangping, Ma Tonghui, Wang Sizhen, Ji Jiaful. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.,Gastric Cancer,2021.

Longtao Huangfu#, Biao Fan#, Gangjian Wang, Xuejun Gan, Shanshan Tian, Qifei He, Qian Yao, Jinyao Shi, Xiaomei Li, Hong Du, Xiangyu Gao, Xiaofang Xing*, Jiafu Ji*.Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer,Cell Death Discov,2022 Jan 10;8(1):5.

Jing Han, Runjia Fu, Cong Chen, Xiaojing Cheng, Ting Guo, Longtao Huangfu, Xiaomei Li, Hong Du , Xiaofang Xing*, Jiafu Ji*. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways,Internatianal Journal of Biological Science,2021 Jul 5;17(11):2841-2852.

Ma Zhonghua, Gao Xiangyu, Shuai Y ou, Wu Xiaolong, Yan Yan, Xing Xiaofang*, Ji Jiafu*. EGR1-mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer.,Cell Proliferation,2021; 54: e12922.

CLDN18.2介导EMT引起胃癌耐药的分子机制及其单抗治疗价值探索, 课题负责人, 2022.1.1～2024.12.31, 北京市自然科学基金

BET Bromodomain 家族蛋白在胃癌中的作用机制及靶向治疗研究, 课题负责人, 2021.1.1～2021.12.31, 北京大学临床医学项目

TOPK激酶通过调控PDL1翻译稳态导致胃癌免疫逃逸的机制研究, 课题负责人, 2026.1.1～2029.12.31, 国家自然科学基金委

EB病毒相关肿瘤浸润B淋巴细胞表型在EB病毒相关胃癌微环境塑造及免疫治疗响应中的作用机制研究, 课题负责人, 2025.1.1～2027.12.31, 院内基金青年科研人才计划-导师科研经费奖励

SIRT1去乙酰化修饰Trim28/BRD4复合物逆转胃癌化疗耐药的机制研究及干预策略, 课题负责人, 2023.1.1～2026.12.31, 国家自然科学基金委

紫杉醇对胃癌中PDL1表达及免疫微环境的调控机制及联合治疗模式探索, 课题负责人, 2019.1.1～2022.12.31, 国家自然科学基金委

紫杉醇通过上调PDL1表达引起胃癌耐药的机制研究, 课题负责人, 2019.1.1～2021.12.31, 北京市医管局培育项目

紫杉醇对胃癌PDL1表达和免疫微环境的调控机制研究, 课题负责人, 2019.1.1～2020.12.31, 北京市医院管理局青年人才培养“青苗”计划

临床决策支持系统研发与全自动一体化系统临床应用评估, 参加者, 2022.11.30～2027.9.30, 国家重点研发计划

胃癌免疫联合治疗策略的开发与验证, 子课题负责人, 2024.12.31～2028.11.30, 癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式	操作
2026	肿瘤学	硕士	学术学位	肿瘤学	推荐免试